FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308121578> ?p ?o ?g. }

• W4308121578 endingPage "5365" @default.
• W4308121578 startingPage "5365" @default.
• W4308121578 abstract "Patients with hormone receptor-positive (HR+), HER2-negative (HER2-) early breast cancer (eBC) with a high risk of relapse often undergo adjuvant chemotherapy. However, only a few patients will gain benefit from chemotherapy. Since classical tumor characteristics (grade, tumor size, lymph node involvement, and Ki67) are of limited value to predict chemotherapy efficacy, multigene expression assays such as the Oncotype DX® test were developed to reduce over- and undertreatment. The IRMA trial analyzed the impact of Recurrence Score® (RS) assessment on adjuvant treatment recommendations.The RS result was assessed in patients with HR+/HER2- unilateral eBC with 0-3 pathologic lymph nodes who underwent primary surgical treatment at the Department for Women's Health of Tuebingen University, Germany. Therapy recommendations without knowledge of the RS result were compared to therapy recommendations with awareness of the RS result.In total, 245 patients underwent RS assessment. Without knowledge of the RS result, 92/245 patients (37.6%) would have been advised to receive chemotherapy. After RS assessment, 56/245 patients (22.9%) were advised to undergo chemotherapy. Chemotherapy was waived in 47/92 patients (51.1%) that were initially recommended to receive it. Chemotherapy was added in 11/153 patients (7.2%) that were recommended to not receive it initially.Using the RS result to guide adjuvant treatment decisions in HR+/HER2- breast cancer led to a substantial reduction of chemotherapy. In view of the results achieved in prospective studies, the RS result is among other risk-factors suitable for the individualization of adjuvant systemic therapy." @default.
• W4308121578 created "2022-11-08" @default.
• W4308121578 creator A5011687402 @default.
• W4308121578 creator A5013148496 @default.
• W4308121578 creator A5014642548 @default.
• W4308121578 creator A5019276717 @default.
• W4308121578 creator A5023008141 @default.
• W4308121578 creator A5025675132 @default.
• W4308121578 creator A5030552991 @default.
• W4308121578 creator A5030678855 @default.
• W4308121578 creator A5040413185 @default.
• W4308121578 creator A5056169995 @default.
• W4308121578 creator A5059250883 @default.
• W4308121578 creator A5085385776 @default.
• W4308121578 creator A5086858990 @default.
• W4308121578 date "2022-10-31" @default.
• W4308121578 modified "2023-10-16" @default.
• W4308121578 title "Recurrence Score® Result Impacts Treatment Decisions in Hormone Receptor-Positive, HER2-Negative Patients with Early Breast Cancer in a Real-World Setting—Results of the IRMA Trial" @default.
• W4308121578 cites W1701849548 @default.
• W4308121578 cites W1961026612 @default.
• W4308121578 cites W2011977835 @default.
• W4308121578 cites W2044702943 @default.
• W4308121578 cites W2095038393 @default.
• W4308121578 cites W2097255042 @default.
• W4308121578 cites W2105882193 @default.
• W4308121578 cites W2113344831 @default.
• W4308121578 cites W2117775530 @default.
• W4308121578 cites W2118632896 @default.
• W4308121578 cites W2126945850 @default.
• W4308121578 cites W2150134401 @default.
• W4308121578 cites W2159427817 @default.
• W4308121578 cites W2160377567 @default.
• W4308121578 cites W2163045991 @default.
• W4308121578 cites W2259802687 @default.
• W4308121578 cites W2289933199 @default.
• W4308121578 cites W2517421365 @default.
• W4308121578 cites W2805734855 @default.
• W4308121578 cites W2899814155 @default.
• W4308121578 cites W2948923376 @default.
• W4308121578 cites W2977150399 @default.
• W4308121578 cites W3011067624 @default.
• W4308121578 cites W3033718997 @default.
• W4308121578 cites W3036685432 @default.
• W4308121578 cites W3092348497 @default.
• W4308121578 cites W3112725886 @default.
• W4308121578 cites W3127186602 @default.
• W4308121578 cites W3165174637 @default.
• W4308121578 cites W3206169364 @default.
• W4308121578 cites W3213008073 @default.
• W4308121578 cites W3215281658 @default.
• W4308121578 cites W4206047930 @default.
• W4308121578 cites W4210303609 @default.
• W4308121578 cites W4213418594 @default.
• W4308121578 cites W4214822522 @default.
• W4308121578 cites W4225725520 @default.
• W4308121578 cites W4226218519 @default.
• W4308121578 doi "https://doi.org/10.3390/cancers14215365" @default.
• W4308121578 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36358784" @default.
• W4308121578 hasPublicationYear "2022" @default.
• W4308121578 type Work @default.
• W4308121578 citedByCount "4" @default.
• W4308121578 countsByYear W43081215782023 @default.
• W4308121578 crossrefType "journal-article" @default.
• W4308121578 hasAuthorship W4308121578A5011687402 @default.
• W4308121578 hasAuthorship W4308121578A5013148496 @default.
• W4308121578 hasAuthorship W4308121578A5014642548 @default.
• W4308121578 hasAuthorship W4308121578A5019276717 @default.
• W4308121578 hasAuthorship W4308121578A5023008141 @default.
• W4308121578 hasAuthorship W4308121578A5025675132 @default.
• W4308121578 hasAuthorship W4308121578A5030552991 @default.
• W4308121578 hasAuthorship W4308121578A5030678855 @default.
• W4308121578 hasAuthorship W4308121578A5040413185 @default.
• W4308121578 hasAuthorship W4308121578A5056169995 @default.
• W4308121578 hasAuthorship W4308121578A5059250883 @default.
• W4308121578 hasAuthorship W4308121578A5085385776 @default.
• W4308121578 hasAuthorship W4308121578A5086858990 @default.
• W4308121578 hasBestOaLocation W43081215781 @default.
• W4308121578 hasConcept C121608353 @default.
• W4308121578 hasConcept C126322002 @default.
• W4308121578 hasConcept C143998085 @default.
• W4308121578 hasConcept C2776694085 @default.
• W4308121578 hasConcept C2777863537 @default.
• W4308121578 hasConcept C2777982462 @default.
• W4308121578 hasConcept C2780849966 @default.
• W4308121578 hasConcept C3018227240 @default.
• W4308121578 hasConcept C530470458 @default.
• W4308121578 hasConcept C71924100 @default.
• W4308121578 hasConceptScore W4308121578C121608353 @default.
• W4308121578 hasConceptScore W4308121578C126322002 @default.
• W4308121578 hasConceptScore W4308121578C143998085 @default.
• W4308121578 hasConceptScore W4308121578C2776694085 @default.
• W4308121578 hasConceptScore W4308121578C2777863537 @default.
• W4308121578 hasConceptScore W4308121578C2777982462 @default.
• W4308121578 hasConceptScore W4308121578C2780849966 @default.
• W4308121578 hasConceptScore W4308121578C3018227240 @default.
• W4308121578 hasConceptScore W4308121578C530470458 @default.
• W4308121578 hasConceptScore W4308121578C71924100 @default.
• W4308121578 hasIssue "21" @default.

• next